Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M
Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M
Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M
Submitted by
admin
on March 26, 2018 - 10:01pm
Source:
Endpoints
News Tags:
Gilead Sciences
Pharma CEOs
John Milligan
executive pay
Headline:
Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M
Do Not Allow Advertisers to Use My Personal information
